Capecitabine and Gemcitabine (CapGem, CG, GemCap) for Advanced Pancreatic and Biliary Tract Cancer. - Wikidata - awgldk - TriplyDB

Capecitabine and Gemcitabine (CapGem, CG, GemCap) for Advanced Pancreatic and Biliary Tract Cancer.

Capecitabine and Gemcitabine (CapGem, CG, GemCap) for Advanced Pancreatic and Biliary Tract Cancer.

http://www.wikidata.org/entity/Q37614142

about

Capecitabine and Gemcitabine (CapGem, CG, GemCap) for Advanced Pancreatic and Biliary Tract Cancer.

http://www.wikidata.org/entity/Q37614142

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Capecitabine and Gemcitabine ( ...... atic and Biliary Tract Cancer.

@en

Capecitabine and Gemcitabine ( ...... atic and Biliary Tract Cancer.

@nl

type

label

Capecitabine and Gemcitabine ( ...... atic and Biliary Tract Cancer.

@en

Capecitabine and Gemcitabine ( ...... atic and Biliary Tract Cancer.

@nl

prefLabel

Capecitabine and Gemcitabine ( ...... atic and Biliary Tract Cancer.

@en

Capecitabine and Gemcitabine ( ...... atic and Biliary Tract Cancer.

@nl

P1433

Q37614142-6339BAAF-9191-40E7-BFA8-2CA2E647FC61

P1476

Q37614142-D41DA1FC-6CC8-4F11-A03C-95DA737EE50E

P2093

Q37614142-2563EECB-427D-43F2-8B4A-8215037D7121

Q37614142-E428BD73-42C9-4414-96FD-01B8B9F0954F

P2860

Q37614142-11806710-8CD3-4FAE-8D36-F99DD2A3F142

Q37614142-25933BF5-12BD-45C4-B13D-922B7434F651

Q37614142-281CA9D0-0FC6-4029-B5DA-F19DE613D364

Q37614142-28F0D407-6323-407E-BDB5-CE3E448B936D

Q37614142-2D099EE2-B359-4D2F-AD9C-B5798E3BC8F0

Q37614142-42222A7C-F596-4602-843D-C6DBD20BF28E

Q37614142-4A393A56-EB4B-485C-9C9E-594D7BF67665

Q37614142-4EBDCC86-3A07-4FF0-8D98-4E0B80E8ADD5

Q37614142-58B597EC-16E3-493F-9068-720C41BD24E6

Q37614142-5CD784B3-75E9-43E5-A189-9C10503BF2A4

P304

Q37614142-6FA14B86-E19C-4FD7-8E0E-ADA9C63D4249

P31

Q37614142-8EF2C969-4005-494F-B39F-1A80009302A9

P356

Q37614142-C16A798E-BD80-4A8A-8FE7-917CC7F31E12

P433

Q37614142-58A93ADB-A4AC-4AE6-98AA-0A0782B16492

P478

Q37614142-09A4050F-7128-4D8B-BD1D-6DAEB2ED5602

P577

Q37614142-45ECBC8F-B1A4-477D-BBCA-C8909699DE4C

P698

Q37614142-B992F425-ECFC-4A4E-AFC5-CF41C27C25E7

P932

Q37614142-4BB0A2D9-9C13-43F2-81E3-916E759C17CB

P356

P1433

Hospital pharmacy

P1476

Capecitabine and Gemcitabine ( ...... atic and Biliary Tract Cancer.

@en

P2093

Dominic A Solimando

http://www.w3.org/2001/XMLSchema#string

J Aubrey Waddell

http://www.w3.org/2001/XMLSchema#string

P2860

Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy

Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study.

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.

A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma.

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer.

Hepatotoxicity of chemotherapy.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer.

P304

127-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1310/HPJ4902-127

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24623866

http://www.w3.org/2001/XMLSchema#string

P932

3940678

http://www.w3.org/2001/XMLSchema#string